New Potential Breast Cancer Drug Identified: Study
Mohammad Ali (@ChaudhryMAli88) Published December 16, 2018 | 03:27 PM
ISLAMABAD, (UrduPoint / Pakistan Point News - 16th Dec, 2018 ) :Scientists, including an Indian-American researcher, have identified a molecule that can help treat breast cancer, giving hope to patients who have become resistant to traditional therapies.
First-in-class drugs are those that work by a unique mechanism - in this case a molecule that targets a protein on the oestrogen receptor of tumour cells, Khaleej Times reported The potential drug offers hope for patients whose breast cancer has become resistant to traditional therapies.
"This is a fundamentally different, new class of agents for oestrogen-receptor-positive breast cancer," said Ganesh Raj, professor at the University of Texas Southwestern (UT Southwestern) Simmons Cancer Center.
"Its unique mechanism of action overcomes the limitations of current therapies," Raj said.
All breast cancers are tested to determine if they require oestrogen to grow and about 80 per cent are found to be oestrogen-sensitive, researchers said.
These cancers can often be effectively treated with hormone therapy, such as tamoxifen, but as many as a third of these cancers eventually become resistant, they said.
The new compound is a potential highly effective, next-line treatment for these patients, said Raj.
Traditional hormonal drugs, such as tamoxifen, work by attaching to a molecule called the oestrogen receptor in cancer cells, preventing oestrogen from binding to the receptor, a necessary step for cancer cells to multiply.
However, the oestrogen receptor can mutate and change its shape over time so that the treatment drug no longer fits neatly with the receptor. When this happens, the cancer cells start multiplying again.
"There has been intense interest in developing drugs that block the ability of the oestrogen receptor - the prime target in most breast cancers - from interacting with the co-regulator proteins that cause a tumour's growth," said David Mangelsdorf, professor at UT Southwestern.
"Blocking such "protein-protein interactions" has been a dream of cancer researchers for decades.
The drug works by blocking other molecules - proteins called co-factors - that also must attach to theoestrogen receptor for cancer cells to multiply.
The new molecule, dubbed ERX-11, mimics a peptide, or protein building block.
Related Topics
Recent Stories
Saka and Odegaard start for Arsenal, Guerreiro in Bayern midfield
Qatar PM says re-evaluating Israel-Hamas mediation role
Govt spokesperson terms allegations of PTI's Marwat against Saudi Arabia 'heinou ..
Minister appreciate UAE’s support for Pakistan economic challenges
Manchester City v Real Madrid Champions League starting line-ups
MIGA's support Pakistan in attracting foreign investments: Federal Minister for ..
Walker returns to captain Man City for Real Madrid clash
Action taken against price list violations in Khanewal district
DC chairs review meeting of DEG
Turkey accuses Israel's Netanyahu of using war 'to stay in power'
Pakistan ranked 5th most vulnerable country to climate change. Tirmizi
Nadal comeback ends in Barcelona Open second round
More Stories From Pakistan
-
Govt spokesperson terms allegations of PTI's Marwat against Saudi Arabia 'heinous attempt'
2 hours ago -
Action taken against price list violations in Khanewal district
2 hours ago -
DC chairs review meeting of DEG
2 hours ago -
Govt to ensure timely water supply in backward areas of Sindh: Jam Shoro
2 hours ago -
Bilawal condemns attack on PPP candidate in Bajaur
2 hours ago -
PRCS observed World Hemophilia Day
2 hours ago
-
Rain forecast across Kashmir on April 18th-19th
2 hours ago -
Local trader killed after abduction
2 hours ago -
Commissioner Karachi chairs meeting on civic problems
3 hours ago -
Blind murder traced, 5 including constable arrested
3 hours ago -
Sindh govt to introduce non-formal education system to facilitate 2 million out of school children
3 hours ago -
Mayor Karachi imposes rain emergency in view of rain forecast: COO KWSC
3 hours ago